surfactin peptide has been researched along with Benign Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, Y; Feng, X; Kong, J; Xiong, Y; Yi, S; Zhu, X | 1 |
| Dong, X; Fang, C; Li, X; Wang, W; Wang, Z; Wu, Y; Zhang, J; Zhou, A | 1 |
2 other study(ies) available for surfactin peptide and Benign Neoplasms
| Article | Year |
|---|---|
Surfactin Ameliorated the Internalization and Inhibitory Performances of Bleomycin Family Compounds in Tumor Cells.
Topics: A549 Cells; Animals; Antineoplastic Agents; Bleomycin; Female; Humans; Lipopeptides; Male; Melanoma; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Neoplasms; Peptides, Cyclic; Reactive Oxygen Species | 2020 |
A novel "mosaic-type" nanoparticle for selective drug release targeting hypoxic cancer cells.
Topics: Animals; Antineoplastic Agents; Carbocyanines; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Drug Delivery Systems; Drug Liberation; Humans; Lipopeptides; Male; Mice; Mice, Nude; Nanoparticles; Neoplasm Transplantation; Neoplasms; Neovascularization, Pathologic; Particle Size; Peptides, Cyclic; Xanthones | 2019 |